Navigation Links
€12 million ($16.9 million) project to develop new tools for malaria control
Date:3/29/2011

LSTM has launched a collaborative project to develop and evaluate new tools to control the spread of malaria in Africa. AvecNet is a five year, 12 million project involving sixteen partners in Africa and Europe, funded by the European Union's Seventh Framework programme.

Because malaria is transmitted by mosquitoes, their effective control is essential to combating the disease. Wide scale use of insecticides on bednets and in interior spraying programmes has dramatically reduced transmission but continued success is dependent on a very limited range of insecticides and other tools.

AvecNet aims to secure the continued effectiveness of these methods into the future by developing and evaluating new insecticides and techniques that will overcome the growing threat of insecticide resistance, as well as designing new tools and interventions to target the mosquitoes that currently evade these control methods. The project also aims to increase existing knowledge about the biology and behaviour of mosquitoes to enable more effective control as urbanisation and other environmental factors alter the balance in this continuing fight against an evolving and formidable opponent.

Dr Hilary Ranson, Head of the Vector Group at LSTM and leader of AvecNet, said: "We need to secure the viability of existing malaria control programmes and expand their scope and reach by developing new methods and tools based upon a vastly increased understanding of how mosquitoes behave and react in different environments.

"We will also rigorously field test existing and prototype tools and techniques to both inform their further development and refinement and to add to the knowledge base from which we can develop further tools and interventions.

"By increasing research capacity in Africa and Europe and uniting people with skills in lots of different fields we are going to generate the momentum to achieve what we hope will be a number of significant breakthroughs in malaria control."


'/>"/>

Contact: Billy Dean
william.dean@liv.ac.uk
01-517-053-272
Liverpool School of Tropical Medicine
Source:Eurekalert

Related biology news :

1. £2 million study to reveal workings of dementia genes
2. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
3. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
4. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
5. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
6. Missouri Botanical Garden mounts milestone 6 millionth herbarium specimen
7. New $11 million center to speed production of new compounds for drug discovery
8. SAIC Awarded $37 Million Contract to Support U.S. Army Program Executive Office - Enterprise Information Systems
9. Eastman Dental Center awarded $1.6 million to find ways to prevent cavities
10. L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million
11. Deep heat solution to 500-million year mystery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology: